Tanios Bekaii-Saab, MD
Enriched profileDavid F. and Margaret T. Grohne Professor of Novel Therapeutics for Cancer Research I; Division Chair, Hematology/Medical Oncology; Vice Chair and Section Chief for Medical Oncology, Department of Internal Medicine; Medical Director, Cancer Clinical Research Office, Mayo Clinic, Phoenix, AZ · Mayo Clinic
Tanios Bekaii-Saab is David F. and Margaret T. Grohne Professor of Novel Therapeutics for Cancer Research I; Division Chair, Hematology/Medical Oncology; Vice Chair and Section Chief for Medical Oncology, Department of Internal Medicine; Medical Director, Cancer Clinical Research Office, Mayo Clinic, Phoenix, AZ at Mayo Clinic. OpenAlex indexes 1,160 publications with 27,504 citations (h-index 82); ClinicalTrials.gov lists 14 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Hematology / Oncology profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Tanios S. Bekaii-Saab is David F. and Margaret T. Grohne Professor of Novel Therapeutics for Cancer Research I at Mayo Clinic (Phoenix, Arizona) / Mayo Clinic College of Medicine and Science. The public record shows 1,160 publications with 27,504 citations (h-index 82), centered on Colorectal Cancer Treatments and Studies, Pancreatic and Hepatic Oncology Research, Cancer Treatment and Pharmacology.
- Most recent indexed publication: 2026 · JCO precision oncology
- Top research focus: Colorectal Cancer Treatments and Studies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 31 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 331.
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
14 registered studies are on record for this person; the itemized rows are on their way. See ClinicalTrials.gov. Why? →
Industry payments
45 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year20256 payments$10,235openpaymentsdata.cms.gov ↗
- Merck Sharp & Dohme LLCProgram year20256 payments
- Ipsen Biopharmaceuticals, IncProgram year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
48.6%Phenothiazine27.7%Prochlorperazine Maleate100%Part D≥25 patientsAtypical Antipsychotic20.9%Olanzapine100%Part D≥18 patientsMetabolism & gastrointestinal
32.4%Serotonin-3 Receptor Antagonist23%Ondansetron Hcl100%Part D≥22 patientsOpioid Agonist9.5%Loperamide100%Part D≥11 patientsSensory organs
18.9%Corticosteroid18.9%Dexamethasone100%Part D≥13 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Long-Term Outcomes and Surgical Conversion After Immunotherapy in Microsatellite Instability-H Biliary Tract Cancers.
JCO precision oncology
Article2026 - Elraglusib and chemotherapy in metastatic pancreatic ductal adenocarcinoma: a randomized controlled phase 2 trial.
Nature medicine
Clinical Trial2026
Most-cited works
by citation count (OpenAlex)Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/tanios-bekaii-saab-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/tanios-bekaii-saab-91200136
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - Other
sciprofiles.com/profile/423977
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →sciprofiles.com ↗
Mentions by others
where others cite or feature them- Other
oncbrothers.com/treatment-algorithm-of-hepatocellular-carcinoma-with-dr-tanios-s-bekaii-saab
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →oncbrothers.com ↗ - Other
soundcloud.com/user-565390384/asco-gi-virtual-meeting-round-up-with-tanios-bekaii-saab
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →soundcloud.com ↗ - Other
threads.com/@mayoclinic/post/DVqer1_iAuu/video-on-this-podcast-episode-of-health-matters-oncologist-dr-tanios-bekaii-saab
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →threads.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →search.asu.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doctor.webmd.com ↗
- Fellowships
Clinical Pharmacology/Experimental Therapeutics and Hematology/Oncology, Tufts University/New England Medical Center
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →search.asu.edu ↗ - Fellow
American College of Physicians (FACP)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →partnersinpancreaticcancer.com ↗
Editorial & leadership roles
journal and society appointments- Disease Group Leader
Gastrointestinal Cancers, Mayo Clinic Comprehensive Cancer Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mayoclinic.org ↗ - Co-leader
Advanced Clinical and Translational Science Program
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mayoclinic.org ↗
Secondary affiliations
appointments beyond the home institution- Adjunct Faculty
Arizona State University
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →search.asu.edu ↗ - Chair
Academic and Community Cancer Research United (ACCRU)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →alumniassociation.mayo.edu ↗ - Co-leader
Hepatobiliary Cancer Sub-Committee, Alliance for Clinical Trials in Oncology
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →alumniassociation.mayo.edu ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mcpress.mayoclinic.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →onclive.com ↗
- Recurring expert commentary contributor
CancerNetwork Tumor Board
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cancernetwork.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
S Rajkumar, MD
Mayo Clinic
Bradley Boeve, MD
Mayo Clinic
Rick Nishimura, MD
Mayo Clinic
Victor Montori, MD
Mayo Clinic